These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 14766474

  • 1. Endometrial cancer and recurrence with hormonal manipulation.
    Ghosh P, Fawzi H.
    J Obstet Gynaecol; 2004 Feb; 24(2):192-3. PubMed ID: 14766474
    [No Abstract] [Full Text] [Related]

  • 2. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
    Abudu EK, Musa O, Adefuye PO, Abdul Kareem FB, Agboola AO, Banjo AA.
    Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
    [Abstract] [Full Text] [Related]

  • 3. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S, Chiyabutra T, Kleabkaew P.
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [Abstract] [Full Text] [Related]

  • 4. Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.
    Wu CJ, Peng YJ, Yu MH, Chen CH.
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):88-90. PubMed ID: 17389201
    [No Abstract] [Full Text] [Related]

  • 5. [Tamoxifen, endometrial cancer risk and liquid based cytology. A paradigmatic case].
    Fambrini M, Buccoliero AM, Pieralli A, Andersson KL, Mattei A, Scarselli G, Taddei G, Marchionni M.
    Minerva Ginecol; 2011 Oct; 63(5):465-70. PubMed ID: 21926955
    [Abstract] [Full Text] [Related]

  • 6. [Endometrial adenocarcinoma appearing during tamoxifen therapy. Report of a clinical case].
    Menada MV, Corticelli A, Giannesi A, Nicoletti L, Podesta M, Rissone R, Fulcheri E.
    Minerva Ginecol; 2000 Dec; 52(12):521-6. PubMed ID: 11310150
    [Abstract] [Full Text] [Related]

  • 7. Intraepithelial G3 adenocarcinoma of the endometrium after tamoxifen treatment.
    Marchesoni D, Driul L, Mozzanega B, Nardelli GB, Parenti A.
    Arch Gynecol Obstet; 2005 Jan; 271(1):62-5. PubMed ID: 15290168
    [Abstract] [Full Text] [Related]

  • 8. High-grade endometrial stromal sarcoma following tamoxifen treatment.
    Engin H.
    Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038
    [No Abstract] [Full Text] [Related]

  • 9. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
    Kuwashima Y, Kurosumi M, Kobayashi Y, Tanuma J, Suemasu K, Higashi Y, Kasamatsu T, Shiromizu K, Matsuzawa M, Kishi K.
    Anticancer Res; 1996 Jan; 16(5A):2993-6. PubMed ID: 8917418
    [Abstract] [Full Text] [Related]

  • 10. Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients.
    Livi L, Paiar F, Meldolesi E, Talamonti C, Simontacchi G, Detti B, Salerno S, Bianchi S, Cardona G, Biti GP.
    Eur J Surg Oncol; 2005 Feb; 31(1):9-12. PubMed ID: 15642419
    [Abstract] [Full Text] [Related]

  • 11. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E, Libera H, Kimmig R, Forsting M.
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [Abstract] [Full Text] [Related]

  • 12. Endolymphatic stromal myosis associated with tamoxifen use.
    Eddy GL, Mazur MT.
    Gynecol Oncol; 1997 Feb; 64(2):262-4. PubMed ID: 9038273
    [Abstract] [Full Text] [Related]

  • 13. [Tamoxifen and endometrial cancer. A case report].
    Orbo A, Lindal S, Mortensen E.
    Tidsskr Nor Laegeforen; 1996 Jun 20; 116(16):1877-8. PubMed ID: 8711699
    [Abstract] [Full Text] [Related]

  • 14. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P, Androutsopoulos G, Zyli P, Michail G, Kardamakis DM, Kourounis G.
    Breast J; 2006 Jun 20; 12(6):578-84. PubMed ID: 17238994
    [No Abstract] [Full Text] [Related]

  • 15. Endometrial cancer within tamoxifen-related polyps in patients with breast cancer.
    Tate S, Yamazawa K, Sekiya S.
    Acta Obstet Gynecol Scand; 2004 Aug 20; 83(8):769-70. PubMed ID: 15255851
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognosis of tamoxifen-associated endometrial cancer.
    Lasset C, Mignotte H, Bonadona V, Chauvin F.
    J Clin Oncol; 1998 Jul 20; 16(7):2573. PubMed ID: 9667283
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.